至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Enhancement of antifungal activity of Burkholderia pyrrocinia JK‐SH007 genetically modified with Bacillus subtilis Chi113 gene.

For Pathol.. 2016-07; 
LM He, JR Ye, JH Ren, L Huang, XQ Wu.
Products/Services Used Details Operation
Gene Synthesis ... Table 2. Oligomeric sequences of all the primers used in this study. Primers, Oligomeric sequences (5'–3')a, Usage of the primers. a All the oligonucleotides were designed by Primer Premier Version 5.0 and synthesized by GenScript Corp. (Nanjing, China). b ... Get A Quote

摘要

Previous studies showed that Burkholderia pyrrocinia JK-SH007 is a potential biocontrol agent of poplar canker disease. In this report, B. pyrrocinia JK-SH007 was genetically modified by introducing the Bacillus subtilis Chi113 gene to enhance its antifungal activity. The green fluorescence of B. pyrrocinia JK-SH007E1 can be detected because of its transformation with plasmid pHKT2-Chi113 containing a gfp reporter gene. Real-time quantitative PCR (qPCR) showed that the B. subtilis Chi113 gene was highly expressed in B. pyrrocinia JK-SH007E1 at mRNA level. The chitinase activity and the antifungal activity of B. pyrrocinia JK-SH007E1 were significantly increased, and the clear halo was visible on the colloi... More

关键词